Temperament and character dimensions of patients with adult separation anxiety disorder

Autor: Tunç Alkin, Seda Mertol
Přispěvatelé: Zonguldak Bülent Ecevit Üniversitesi
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Popis: WOS: 000306535300012
PubMed: 22440427
Background: There is growing evidence suggesting that separation anxiety can occur in adults. We aimed to determine temperament and character dimensions in patients with adult separation anxiety disorder (ASAD) compared to patients with panic disorder (PD) and healthy subjects. Methods: The study sample included 77 outpatients with ASAD, 44 outpatients with a PD with or without agoraphobia diagnosis, and 35 healthy subjects. ASAD diagnoses were confirmed with Structured Clinical Interview for Separation Anxiety Symptoms. Other measures included Adulthood Separation Anxiety Checklist, Separation Anxiety Symptom Inventory, and Temperament and Character Inventory (TCI). Group comparisons according to presence or absence of PD comorbidity in ASAD were also done. Results: Patients with ASAD scored higher in harm avoidance (HA) and scored lower in self-directedness (SD) compared to PD and control groups. Moreover, both PD patients and ASAD patients scored higher in RD, and self-transcendence dimensions than control subjects. All subscales of HA (anticipatory worry, fear of uncertainty, shyness, and fatigability) were significantly higher than controls. While HA scores were not different between ASAD and 'ASAD + PD' patients, HA levels of both groups were higher than PD alone and control groups. SD scores of patients with ASAD were lower than PD and control groups. Limitations: Cross-sectional design and ASAD group have other anxiety disorders comorbidity which might affect the results. Conclusion: Similar to PD and other anxiety disorders HA and RD was higher, and SD was lower in patients with ASAD compared to healthy subjects. Observed TCI profile is related to the ASAD itself since depression comorbidity was controlled. (C) 2012 Elsevier B.V. All rights reserved.
Ely-Lilly; Janssen-CilagJohnson & Johnson USAJanssen Biotech Inc; PfizerPfizer
Dr. Allan served as a researcher to Pfizer, and sponsored in congresses by Ely-Lilly, Janssen-Cilag, and Pfizer in the previous 3 years.
Databáze: OpenAIRE